The program times are listed in Central European Time (CEST)

Displaying One Session

INDUSTRY SESSION
Date
Wed, 02.06.2021
Session Type
INDUSTRY SESSION
Session Time
17:00 - 18:30
Room
Hall A
Session Description

MiniMed™ 780G System: Improving Clinical Outcomes while Reducing Diabetes Management Burden - Industry Symposium Supported by Medtronic

Session description - Innovation of technology in type 1 diabetes has transformed the therapy and significantly improved both clinical and patient related outcomes. In this symposium, the most recent data on the transformation brought by the introduction of automated insulin delivery system - the MiniMed™ 780G system-, on goals obtainment in real world will be presented. The opportunities brought by these to onboard a wider population of people with diabetes, even those without extensive exposure to technology, will be demonstrated. Further innovation toward extending infusion sets wear to 7 days, and its performance with automated insulin delivery system will be presented, as an additional step toward improving users’ experience. A look toward the future innovation will be offered by the leaders of Medtronic R&D

INDUSTRY SESSION

MiniMed™ 780G System: Improving Clinical Outcomes while Reducing Diabetes Management Burden

Date
Wed, 02.06.2021
Lecture Time
17:00 - 17:00
INDUSTRY SESSION

Industry Symposium Supported by Medtronic

Date
Wed, 02.06.2021
Lecture Time
17:00 - 17:00
INDUSTRY SESSION

The Role of Technology in Type 1 Diabetes Beyond the Pandemic

INDUSTRY SESSION

The MiniMed™ 780G System : Real-Word Evidence from the First 4,000 Users

INDUSTRY SESSION

From MDI Therapy to Automated Insulin Delivery Systems : Clinical Evidence

INDUSTRY SESSION

Innovation in Infusion Sets: Extending the Wear for a Better Experience

INDUSTRY SESSION

Looking Toward the Future:  Next Steps in the Advancement of Closing the Loop